Estrogens and human cardiovascular physiology

Reproduction, Fertility and Development

Volumn 13, Issue 4, 2001, Pages 261-272

  Komesaroff, P A ^a   Sudhir, K ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

BIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MALE; MENOPAUSE; REVIEW; VASCULARIZATION;

ANIMALS; AROMATASE; BLOOD COAGULATION; CARDIOVASCULAR PHYSIOLOGY; ESTROGENS; ESTROGENS, NON-STEROIDAL; FEMALE; GLUCOSE; HUMANS; ISOFLAVONES; LIPOPROTEINS; MALE; PHYTOESTROGENS; PLANT PREPARATIONS; RISK FACTORS; STRESS;

EID: 0035211192     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/RD00127     Document Type: Review

References (100)

1. Natural androgens inhibit male atherosclerosis: A study in castrated, cholesterol-fed rabbits
2. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with non-insulin dependent diabetes
3. Biotransformation of oral dehydroepiandrosterone in elderly men: Significant increase in circulating estrogens
4. Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men
5. Sex differences in coronary heart disease: Why are women so superior? The 1995 Ancel Keys Lecture
6. Hormone replacement therapy, heart disease, and other considerations
7. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture
8. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men
9. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
10. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men
11. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression
12. Stress responses in male and female engineering students
13. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease
14. 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: Similar effects in cells from postmenopausal females and in males
15. Aromatase and estrogen receptor immuno-reactivity in the coronary arteries of monkeys and human subjects
16. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: A controlled feeding study
17. Acute effects of ethanol on sex hormones in non-alcoholic men and women
18. The vascular protective effects of estrogen
19. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bio-available fractions in community-dwelling men
20. Sex differences in psychoneuroendocrine reactions to examination stress
21. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study
22. Acute vascular effects of estrogen in postmenopausal women
23. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
24. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females
25. Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men
26. Hormone therapy to prevent disease and prolong life in postmenopausal women
27. Postmenopausal hormone therapy and mortality
28. Therapeutic potential of selective estrogen receptor modulators
29. Behavioral correlates of plasma sex hormones and their relationships with plasma lipids and lipoproteins in Japanese men
30. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine
31. Estrogen increases endothelial nitric oxide by a receptor-mediated system
32. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
33. Variant estrogen and progesterone receptor messages in human vascular smooth muscle cells
34. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS). Research Group
35. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
36. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells
37. Mental stress-induced myocardial ischemia and cardiac events
38. Effects of estradiol on circulating P-selectin
39. Human vascular smooth muscle cells contain functional estrogen receptor
40. Human vascular smooth muscle cells express an estrogen receptor isoform
41. Gender difference in improvement of endothelium-dependent vasodilatation after estrogen supplementation
42. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
43. Cortisol and estradiol: Nongenetic factors for hyperhomocyst(e)inemia
44. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
45. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
46. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women
47. A novel, nongenomic action of estrogen on the cardiovascular system
48. Variations in hormonal responses to stress during the estrous cycle in sheep
49. Estrogen supplementation improves vascular reactivity in hypogonadal men
50. Effects of estrogen on glucocorticoid and catecholamine responses to stress in perimenopausal women
51. Aromatase inhibition alters vascular reactivity and arterial compliance in men: A possible vascular role for endogenous sex hormones in males
52. Cloning of a novel receptor expressed in rat prostate and ovary
53. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
54. Thrombotic diseases in young women and the influence of oral contraceptives
55. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury
56. Estrogen inhibits mechanical strain-induced mitogenesis in human vascular smooth muscle cells via down-regulation of Sp-1
57. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women
58. Origin of estrogen in normal men and in women with testicular feminization
59. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity
60. Arterial reactivity is enhanced in genetic males taking high dose estrogens
61. Estrogen and the blood vessel wall
62. Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: Atherogenic relationships
63. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor
64. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
65. Calcium antagonistic effect of natural and synthetic estrogens-investigations on a nongenomic mechanism of vascular action
66. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women
67. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
68. Long-term estrogen therapy improves vascular function in male to female transsexuals
69. Effects of estrogen and progesterone on plasma platelet-activating factor-acetylhydrolase activity and low-density lipoprotein cholesterol concentration in men
70. Effect of gender differences and estrogen replacement therapy on vascular reactivity
71. The association of hyperestrogenemia with coronary thrombosis in men
72. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts
73. Estrogen acutely abolishes abnormal cold-induced coronary constriction in men
74. Circulating nitric oxide (nitrite/nitrate). Levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study
75. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption
76. Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors: The FINRISK Hemostasis Study
77. Hormone replacement therapy and circulating ICAM-1 in post-menopausal women-a randomised controlled trial
78. The relationships of testosterone, estradiol, dehydroepiandrosterone-sulfate and sex hormone-binding globulin to lipid and glucose metabolism in healthy men
79. Aromatase expression in health and disease
80. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
81. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells
82. Effect of obesity on prostatic hyperplasia: Its relation to sex steroid levels
83. Post-menopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses Health Study
84. Sex differences in physiological responses to stress and in coronary heart disease: A causal link?
85. Mechanisms of estrogen-induced vasodilatation: In vivo studies in canine coronary conductance and resistance arteries
86. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women
87. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man
88. Endothelial dysfunction in a man with disruptive mutation in estrogen-receptor gene
89. Potential health benefits of dietary phytoestrogens-a review of the clinical epidemiological and mechanistic evidence
90. Findings leading to discontinuation of the 2.5-mg day estrogen group
91. Initiative clinical trial and observational study
92. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: A one-year, double-blind, placebo-controlled study
93. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post-menopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
94. Treatment and survival of men with cancer of the prostate
95. Identification of authentic estrogen receptor in cultured endothelial cells: A potential mechanism for steroid hormone regulation of endothelial function
96. Ethanol-induced increase in cytosolic estrogen receptors in human male liver: A possible explanation for biochemical feminization in chronic liver disease due to alcohol
97. Rapid effects of mineralocorticoids on sodium-proton exchanger: Genomic or non-genomic pathway?
98. Estrogen modulates responses of atherosclerotic coronary arteries
99. Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates
100. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management